ClinicalTrials.gg
RecruitingNCT07440134CALYPSOUpdated Sep 17, 2026

Visual and Postural Behavior in Myopic and Non-Myopic Teenagers

An interventional study of Ophtalmic measurements and Visuo-postual measurements in Teenagers and Myopia, sponsored by Essilor International. Recruiting at 1 site in France. Open to participants aged 12 Years to 17 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-17.

Sponsored by Essilor International · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Started Apr 2026; still recruiting 7 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Non-randomized
Ages
12 Years to 17 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-14

Among 28 studies in Myopia by EssilorLuxottica — 14 open to participants now, 19 under way, none of them phase 3. Myopia · EssilorLuxottica.

Planned enrollment
7th of 28
100 · median 52
Started
2026
with 8 others
No phase
28 of 28
14 open now
Primary completion
2027-05
later than 9 of 18 live
Registered
20th of 28
by date

Among the 28 studies in Myopia by EssilorLuxottica, this one is the 7th largest by planned enrollment, is one of 9 that started in 2026, is one of 28 with no phase, reaches primary completion later than 9 of the 18 other live ones, and was the 20th registered.

Myopia

1,160 studies on the registry are indexed under Myopia; 226 are open to participants now.

Browse Myopia studies →

Open to participants now

14 of the 28 studies in Myopia by EssilorLuxottica are open now, in 5 countries. Recruiting first, the newest first:

8 more — sign in →

By country, each count listing its studies:

All 14 open studies →

Who these studies take

Of the 122 Myopia studies recruiting now, 19 (16%) set no upper age limit and 102 (84%) stop at 75 or younger; 86 take children under 18; 53 take healthy volunteers.

This study: 12 Years to 17 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 28 studies in Myopia by EssilorLuxottica, or all of them as a file.
02

Study summary

The goal of this observational study is to learn whether different types of eyeglasses prescription and different types of lenses change how close teenagers hold objects when looking at them up close. The study includes adolescents who are non-myopic and adolescents who are myopic and wear either single-vision lenses or lenses slowing down myopia progression.

The main questions it aims to answer are:

Do teenagers in these three groups use different average working distances (eye-to-object distance) during everyday tasks?

Does wearing Essilor® Stellest® lenses change working distance compared with wearing single-vision lenses?

Researchers will compare the three groups to see if their working distances differ.

Participants will:

Complete an initial optometric eye examination.

Come for a second visit where they perform everyday activities while wearing a motion-capture system that measures how they move and how far they hold objects.

03

Conditions studied

  • Teenagers
  • Myopia

Browse trials for

Keywords

  • Myopia
  • Ophthalmological measurements
04

Who can participate

Ages eligible
12 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Volunteer adolescent, fluent in French, able to follow protocol and read and write
  • Aged between 12 and 17 years and 6 months
  • Adolescent with no history, according to the participant and/or their legal representatives, of any pathology, deficit, or disorder that could interfere with visual or cognitive functions.
  • If the subject wears glasses, they must have an ophthalmic prescription dated within the last year, certifying that a consultation was carried out during the previous year
  • If the subject wears Essilor® Stellest® 1.0 lenses, they must have worn them for at least two (2) consecutive months prior to inclusion in the study.
  • If the subject is nearsighted: -6.5D ≤ equivalent sphere ≤ -0.5D with usual correction
  • If the subject is not nearsighted: -0.5 \< equivalent sphere ≤ +2.5

Exclusion criteria

Exclusion Criteria:

  • Age \< 12 years
  • Age > 17 years and 6 months
  • Pregnant or breastfeeding women (Article L1121-5)
  • Persons (legal representatives or subjects) deprived of their liberty by a judicial or administrative decision and persons hospitalized without consent pursuant to Articles L. 3212-1 and L. 3213-1 who are not covered by the provisions of Article L. 1121-8 and persons admitted to a health or social care facility for purposes other than research
  • Participants who are currently excluded from another study
  • All categories of persons who are particularly protected under French law are excluded from this research (Articles L1121-5 to L1121-9 of the Public Health Code)
  • Declared neurological deficit, in particular a history of epileptic pathology or sensorimotor coordination disorders, vestibular or cerebellar pathology (e.g., balance disorders)
  • Severe declared eye disease involving loss of visual field, such as glaucoma, involving loss of acuity and severe discomfort in low-light or overly bright environments, such as retinitis pigmentosa, or declared and treated dry eye syndrome.
  • Gougerot-Sjögren syndrome or declared dry eye syndrome
  • Declared aphakia or pseudophakia (intraocular implant)
  • Declared systemic pathology, medical treatment, or medication with an effect on vision
  • People with declared muscle paralysis
  • Binocular vision problems such as amblyopia, strabismus, or nystagmus
  • Children of employees or employees of Essilor International, Luxottica, GrandVision, and their subsidiaries
  • Individuals who have undergone previous refractive surgery, have a history of strabismus surgery, or have a history of any type of eye surgery
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    non-myopic teenagers

    Device: Ophtalmic measurements · Behavioral: Visuo-postual measurements

  • Experimental
    myopic teenagers wearing Essilor® Stellest® lenses

    Device: Ophtalmic measurements · Behavioral: Visuo-postual measurements

  • Experimental
    myopic teenagers wearing single vision lenses

    Worn lenses do not have a myopia-control effect

    Device: Ophtalmic measurements · Behavioral: Visuo-postual measurements

Interventions

  • DeviceOphtalmic measurements

    Participants will undergo a standard ophthalmic examination during the initial visit. All procedures are non-invasive, non-ionising, and conducted using devices routinely employed in clinical ophthalmic practice.

  • BehavioralVisuo-postual measurements

    The behavioral part of the study consists of a set of tasks designed to assess eye movements and visual behavior in both controlled and ecological conditions. Participants perform everyday activities while eye movements and body motion are recorded using an eye tracker and motion capture systems.

06

What researchers measure

Primary outcomes

  1. Working distance using motion capture system

    Quantitative assessment of working distance in meters during near vision tasks using a motion capture system

    Time frame: From enrollment to 3 months after enrollment

Secondary outcomes

  1. Gaze behavior during near vision tasks accessed with an eye-tracking system

    Assessment of eye movements (spatial coordinates) during near vision tasks

    Time frame: From enrollment to 3 months after enrollment

  2. Posture, eye-head coordination during near-vision tasks (with motion capture system)

    Quantitative evaluation of postural behavior (spatial coordinates of body parts) while performing near vision tasks.

    Time frame: From enrollment to 3 months after enrollment

  3. Correlation coefficient (R2) between optometric profile and near-vision behavior

    Statistical analysis of the association between participants' optometric characteristics and their near vision behavioral patterns.

    Time frame: From enrollment to 3 months after enrollment

07

Study locations

1 of 1 sites recruiting
  • Paris Bastille
    Paris, 75012, France
    Recruiting
    • David Rio, Main investigator · Contactriod@essilor.fr · +33(0)155964840
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2026 (actual). Primary completion is estimated for May 2027, 13 months after the start.

Of 234 industry-sponsored interventional studies with no phase under Myopia, half reached primary completion within 6 months of starting (the median), counting those still running; a quarter within 2 and three quarters within 24. This study's planned 13 months is above that.

Counting every sponsor, half of 434 studies reached it within 14 months; a quarter within 3 and three quarters within 34.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 12, 2026
First posted
Feb 27, 2026
StartActual
Apr 3, 2026
Primary completionEst.
May 2027
CompletionEst.
May 2027
Last update
Sep 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07440134
Responsible party
Sponsor
First posted
Feb 27, 2026
Start date
Apr 3, 2026
Primary completion
May 2027 (estimated)
Completion
May 2027 (estimated)
Last update
Sep 17, 2026

Study contacts

David Rio, Phd
Contact
riod@essilor.fr
+33(0)155964840
Sébastien Fricker
Contact
frickers@essilor.fr
+33155964970

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion